Position history for VANGUARD GROUP INC's holdings in IMMUNITYBIO INC
VANGUARD GROUP INC holds 32.8M shares of IBRX (IMMUNITYBIO INC), worth $64.9M as of 2025-Q4. The position was increased (++18.5% shares). IBRX represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$64.9M
Current Shares
32.8M
Total Value Change
+$2M
Total Shares Change
+15.9M
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 32.8M |
+18.5% |
| $64.9M |
| 0.0% |
| $1.98 |
35 |
| 2025-Q3 | Increased | 27.7M | +26.8% | $68M | 0.0% | $2.57 | 37 |
| 2025-Q2 | Increased | 21.8M | +7.2% | $57.6M | 0.0% | $2.70 | 32 |
| 2025-Q1 | Increased | 20.3M | +17.4% | $61.2M | 0.0% | $3.14 | 34 |
| 2024-Q4 | Increased | 17.3M | +2.5% | $44.4M | 0.0% | $2.68 | 30 |
| 2024-Q3 | New | 16.9M | - | $62.9M | 0.0% | $3.93 | 41 |